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Mitochondrial reactive oxygen species
a b s t r a c t
A recent study revealed a mechanism of delaying aging in yeast by a natural compound which speciﬁcally
impacts mitochondrial redox processes. In this mechanism, exogenously added lithocholic bile acid
enters yeast cells, accumulates mainly in the inner mitochondrial membrane, and elicits an age-related
remodeling of phospholipid synthesis and movement within both mitochondrial membranes. Such
remodeling of mitochondrial phospholipid dynamics progresses with the chronological age of a yeast cell
and ultimately causes signiﬁcant changes in mitochondrial membrane lipidome. These changes in the
composition of membrane phospholipids alter mitochondrial abundance and morphology, thereby
triggering changes in the age-related chronology of such longevity-deﬁning redox processes as
mitochondrial respiration, the maintenance of mitochondrial membrane potential, the preservation of
cellular homeostasis of mitochondrially produced reactive oxygen species, and the coupling of electron
transport to ATP synthesis.
& 2014 The Authors. Published by Elsevier B.V. All rights reserved.
A body of evidence supports the notion that mitochondria
regulate cellular aging in evolutionarily distant eukaryotic organ-
isms [1–3]. These organelles compartmentalize various redox
processes known to be essential for establishing the rate of cellular
and organismal aging. Such longevity-deﬁning redox processes in
mitochondria include the coupling of electron transport to ATP
synthesis, modulation of mitochondrial membrane potential,
maintenance of cellular homeostasis of reactive oxygen species
(ROS), and formation and release of certain metabolites and
macromolecules that can set off a pro- or anti-aging cellular
pattern [2,4–10]. Several small molecules have been shown to
delay cellular and organismal aging in eukaryotes across phyla by
modulating some of the mitochondria-conﬁned redox processes.
After being sorted to the mitochondrial matrix, the inner mito-
chondrial membrane (IMM) or the outer mitochondrial membrane
(OMM), these anti-aging pharmaceuticals act as rechargeable
antioxidants that attenuate oxidative damage to membrane pro-
teins and/or phospholipids [11–17]. Our recent study revealed a
previously unknown mechanism of delaying cellular aging by a
mitochondrially targeted natural compound which speciﬁcally
impacts mitochondrial redox biology [18]. The name of this
compound is lithocholic acid (LCA), a bile acid which we identiﬁed
in a high-throughput chemical genetic screen for small molecules
extending longevity of chronologically aging yeast [19]. In the
mechanism that we discovered, an exogenously added LCA enters
yeast cells and accumulates mostly in the IMM; a minor portion of
this bile acid is also conﬁned to the OMM (Fig. 1). The pools of LCA
accumulated in both mitochondrial membranes elicit an age-
related remodeling of phospholipid synthesis and movement
within the IMM and OMM (Fig. 1). Such speciﬁc remodeling of
mitochondrial phospholipid dynamics progresses with the chron-
ological age of a yeast cell and ultimately causes signiﬁcant
changes in mitochondrial membrane lipidome. These changes
include (1) a decrease in the relative levels of phosphatidyletha-
nolamine (PE), cardiolipin (CL) and monolysocardiolipin (MLCL)
within mitochondrial membranes; and (2) an increase in the
relative levels of phosphatidic acid (PA), phosphatidylserine (PS),
phosphatidylcholine (PC) and phosphatidylglycerol (PG) within
mitochondrial membranes (Fig. 1). In turn, the LCA-driven changes
in the composition of mitochondrial membrane phospholipids
cause: (1) a substantial enlargement of mitochondria; (2) a sig-
niﬁcant decrease in mitochondrial number; (3) a reduction in the
fraction of mitochondria with cristae extending from the IMM; and
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(4) a build-up within the mitochondrial matrix of abundant cristae
disconnected from the IMM (Fig. 1). These elicited by LCA major
alterations in mitochondrial abundance and morphology in turn
cause speciﬁc changes in the age-related chronology of such
longevity-deﬁning redox processes conﬁned to mitochondria as
respiration, the maintenance of mitochondrial membrane poten-
tial, the preservation of cellular homeostasis of mitochondrially
produced ROS, and the coupling of electron transport to ATP
synthesis (Fig. 1). The elevated efﬁciencies of mitochondrial
respiration, membrane potential maintenance and ATP synthesis
observed in chronologically “old”, quiescent yeast cultured with
LCA (as compared to those in age-matched cells cultured without
LCA) are known to delay aging of yeast cells by increasing their
long-term viability [18–23]. Furthermore, the raised sub-lethal
concentration of mitochondria-generated intracellular ROS
detected in this yeast (Fig. 1) has been demonstrated to delay
cellular aging because it stimulates a signaling network promoting
the long-term stress resistance of yeast cells [5–7,18–21]. Impor-
tantly, the longevity-extending pattern of mitochondrial redox
processes characteristic of chronologically “old”, quiescent yeast
cultured with LCA (Fig. 1) is likely due to the lowered below a toxic
threshold intracellular concentration of ROS seen in chronologi-
cally “young”, non-quiescent yeast cultured in the presence of this
bile acid [18,19]. Indeed, a reduced ROS level in chronologically
“young” yeast cells exposed to certain anti-aging interventions has
been shown to lessen the extent of oxidative damage to mito-
chondrial macromolecules in these cells, thereby allowing them to
maintain the functionality of macromolecules involved in mito-
chondrial respiration, membrane potential maintenance and ATP
synthesis when these cells become chronologically “old”
[18,19,21,23]. Ultimately, the elicited by LCA changes in the age-
related chronology of these mitochondrial redox processes extend
longevity of chronologically aging yeast.
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Fig. 1. A mechanism of delaying aging in yeast by a mitochondrially targeted compound which impacts mitochondrial redox biology. Lithocholic bile acid (LCA) enters yeast
cells, accumulates mainly in the inner mitochondrial membrane, and elicits a remodeling of phospholipid synthesis and movement within both mitochondrial membranes.
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phospholipids alter mitochondrial abundance and morphology, thereby triggering changes in the age-related chronology of several longevity-deﬁning redox processes
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